CAPSTONE INVESTMENT ADVISORS, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 34 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$6,298,800
-59.2%
7,250,000
-59.2%
0.03%
-63.2%
Q2 2023$15,442,987
-28.2%
17,750,000
-28.3%
0.08%
-30.3%
Q1 2023$21,519,892
+34.7%
24,750,000
+38.2%
0.11%
-6.0%
Q4 2022$15,972,145
-13.4%
17,908,000
-12.3%
0.12%
+4.5%
Q3 2022$18,449,000
+4.4%
20,408,0000.0%0.11%
+29.1%
Q2 2022$17,663,000
-5.1%
20,408,0000.0%0.09%
+68.6%
Q1 2022$18,622,000
+104.6%
20,408,000
+106.0%
0.05%
+240.0%
Q4 2021$9,103,0009,908,0000.02%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 67,736,000$60,446,9294.40%
BRAIDWELL LP 131,834,000$117,582,7453.94%
DeepCurrents Investment Group LLC 38,391,000$34,368,1761.34%
SHENKMAN CAPITAL MANAGEMENT INC 16,861,000$14,946,8630.93%
Context Capital Management, LLC 12,489$11,1390.82%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$68,630,3670.71%
ABSOLUTE INVESTMENT ADVISERS, LLC 3,500,000$3,113,2500.47%
Aequim Alternative Investments LP 18,000,000$16,054,2000.44%
Ionic Capital Management LLC 2,000,000$1,781,5550.42%
Verition Fund Management LLC 27,771,000$24,768,9550.39%
View complete list of NOVOCURE LTD shareholders